Interventional Radiology

    Since October 2020, due to the adoption of the organizational law of this hospital by the Legislative Yuan, the original Department of Urogenital Radiology was changed to the Department of Interventional Radiology (Interventional Radiology). Director Wang Jiahuai of the former Department of Urogenital Radiology succeeded him. Director Wang retired on January 16, 2033. .

    Dr. Luo Zhaobao was officially promoted on April 1, 2020. On February 1, 2015, Dr. Luo was transferred to the position of director of the Department of Neuroradiology and temporarily served as the director of the undergraduate department. On March 1, 2020, Dr. Shen Shuhui was officially promoted to department director.

    The main task of the Interventional Radiology Department (hereinafter referred to as IR) is to perform interventional diagnosis (such as lesion tissue sectioning under computer tomography guidance) or interventional treatment (such as embolization of arteriovenous malformations, tumors) with the assistance of imaging. IR has been developing in our department for more than 30 years and has performed more than 20,000 cases of interventional radiology. Interventional radiology can be divided into neuroradiology (Interventional Neuroradiology, INR) and non-neurobody intervention (body IR). Neuroradiology intervention was established more than 30 years ago. Professor Deng Muhuo introduced it to Taiwan from abroad and treated many cases of intracranial dynamic malformations and fistulas, changing the traditional treatment methods for cerebrovascular diseases. Instead, the minimally invasive INR method, especially the treatment of traumatic direct carotid cavernous fistula by directly puncturing the eye socket through image fluoroscopy, is unique in the world. Under Professor Deng's guidance, neurointerventional therapy has made great progress in the treatment of intracranial aneurysms, arteriovenous malformations, bleeding in the mouth, nose and neck, and preoperative treatment of nerve tumors or blood flow embolism.

    In the 1990s, neurointerventional therapy was developing rapidly in the treatment and prevention of ischemic stroke. In 1996, our hospital began to perform stent placement for carotid artery stenosis and began to develop thrombolytic therapy for acute ischemic stroke. In 1994, Professor Deng began to develop vertebroplasty. Neurointerventional therapy has achieved outstanding results after more than 30 years of development under the guidance of Professor Deng. Currently, about 300 patients receive INR treatment and treatment every year. In addition to technical and More than 60 domestic and foreign papers have been published on the improvement of treatment effects.

    In terms of the progress of interventional radiotherapy in the body, under the guidance of President Junqian and Director Jiang Renhui more than 30 years ago, currently more than 1,000 patients receive interventional radiotherapy in our department every year. These treatments include embolization treatment of liver tumors. Including transarterial embolization, alcohol injection or thermal radiofrequency. In recent years, transarterial treatment using radioembolization has also provided alternative treatment for a small number of patients. Recently, due to the rapid development of science and technology, cryotherapy for systemic tumors has also made great progress in our department. In addition to traditional hepatobiliary drainage, renal drainage, and image-guided tissue sectioning, there has also been a steady development.

    The short-term goal of the Department of Interventional Radiology is to establish standard procedures for each interventional radiotherapy, maintain patient safety, and establish high-quality interventional radiotherapy. The medium-term goals are to train talents, develop new technologies, and publish papers. The long-term goal is to make our hospital a benchmark hospital in Taiwan and the Asia-Pacific region.